Infographic: Considerations for developing a smart biomarker assay
This infographic focuses on the key considerations to take into account when developing a smart biomarker assay, walking through how compounds should be handled, what the endogenous concentration of the biomarker is and what guidance to follow for the study endpoint.
This is a part of our In the Zone feature with Alturas Analytics, Inc. on smart biomarker assays. To find out more, please visit our feature homepage
BZ In the Zone BZ Alturas infographic biomarkers (1)
[Illustrated by Hannah Morton]
In association with:
